Frazier Life Sciences Public Fund, L.P.

6 filings 4 distinct issuers Active 2023-09-27 → 2026-08-11

Track Record

Total filings

1 SCHEDULE 13D · 2 SCHEDULE 13D/A · 2 SCHEDULE · 1 SC

Distinct issuers

67% issuer diversity

Median stake

9.17%

2,165,790 avg shares

AI briefs cached

0/6

intent-classified filings

Backtested Performance · post-filing returns (split + dividend adjusted)

Median 30d

0.0%

across 1 filings · win rate 0%

Median 60d

0.0%

across 1 filings · win rate 0%

Median 90d

0.0%

across 1 filings · win rate 0%

Median 1y

—

across 0 filings · win rate —

Anchor: closest trading day on/after filing's date_of_event. Source: Yahoo Finance daily adj_close. Past performance is not indicative of future results.

Filings · 6 total

Filed	Form	Issuer	Stake	Shares
2026-08-11	SCHEDULE 13D	Attovia Therapeutics, Inc.ATTO	13.50%	760,327	view →
2026-08-10	SCHEDULE 13D/A	MBX BIOSCIENCES, INC.MBX	—	1,429,573	view →
2026-05-21	SCHEDULE 13D/A	KalVista Pharmaceuticals, Inc.	2.30%	1,249,165	view →
2025-09-30	SCHEDULE	MBX Biosciences, Inc.MBX	11.70%	5,224,095	view →
2025-09-17	SCHEDULE	HilleVax, Inc.	—	—	view →
2023-09-27	SC	HilleVax, Inc.	—	—	view →

Alert me when Frazier Life Sciences Public Fund, L.P. files anything

Free. We email you when criteria match. One-click unsubscribe in every email.

Track this filer's every move in real time.

Custom alerts on filer activity · full feed access · daily intelligence · API. From $49/mo.

See pricing →